Evidence map›Paper›PMID 42331970›Full record

ArticleScientific reports2026

Prediction of distribution areas of the rare Iris kuschakewiczii B.Fedtsch. species across its range using the MaxEnt model.

Aruzhan Alikhanova, Saule Abugalieva, Shyryn Almerekova, Yerlan Turuspekov

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aruzhan AlikhanovaInstitute of Plant Biology and Biotechnology, 050040, Almaty, Kazakhstan.
Saule AbugalievaInstitute of Plant Biology and Biotechnology, 050040, Almaty, Kazakhstan.
Shyryn AlmerekovaInstitute of Plant Biology and Biotechnology, 050040, Almaty, Kazakhstan.
Yerlan TuruspekovInstitute of Plant Biology and Biotechnology, 050040, Almaty, Kazakhstan. yerlant@yahoo.com.

Funding

Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP23483825
6 · The paper itself

Abstract

Iris kuschakewiczii B.Fedtsch. is a rare ornamental plant endemic to the Northern Tien Shan mountains. The analysis of the species' distribution range is important given the declining habitat area. This study employed MaxEnt to project the distribution of I. kuschakewiczii under current and three future climate change scenarios (SSP126, SSP245, SSP585) for two time periods (the 2050s and the 2090s). Prediction models showed high validity (AUC = 0.997), strong accuracy, and reliability. Moreover, key environmental variables affecting the distribution of I. kuschakewiczii were identified. It included Weight and Percentage of Sand (70%), Temperature Seasonality (~ 2300), and Elevation (700-1300 m above the sea level). Highly suitable distribution areas were mainly found in the Chu-Ili Mountains (Southeastern Kazakhstan). The analysis showed that only 26.7% of the total highly suitable area is protected by reserves and nature parks, underlying the need for conservation. The recently founded Kurty Valley Important Plant Area in Kazakhstan provides a strong foundation for the scientific conservation of I. kuschakewiczii and other rare and endangered plants. This research provides insights into the potential dynamics of habitat distribution for the endangered I. kuschakewiczii and offers a basis for strengthening cooperative international conservation and sustainable management strategies in the face of climate change.

Indexed as

Iris PlantClimate ChangeConservation of Natural ResourcesEcosystemClimate changeConservation strategiesIris kuschakewicziiMaximum entropySpecies distribution models

Identifiers

PMID42331970
PMCPMC13575233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.